Galimedix Therapeutics to present promising pre-clinical data with next generation oral amyloid beta aggregation modulator at AD/PDTM 2026 Conference
· galimedix therapeutics, inc.
AI Briefing
- Galimedix Therapeutics to present promising pre-clinical data with next generation oral amyloid beta aggregation modulator at AD/PDTM 2026 Conference
- Kensington, MD, USA and Munich/Martinsried, Germany
- GLOBE NEWSWIRE
Advertisement